title: Assuring Quality Cancer Survivorship Care: We've Only Just Begun.
abstract: Clinical practice guidelines, quality metrics, and performance improvement projects are the key tools of the national movement to improve and assure quality cancer care. Each of these evaluation instruments is intended to assess quality from a unique perspective, including that of the individual provider, the practice/hospital, and the health care system. A number of organizations have developed or endorsed quality measures specific to cancer, however, these have not formally included survivorship measures. Fortunately, the American Society of Clinical Oncology (ASCO), the National Comprehensive Cancer Network, the American Cancer Society, and the American College of Surgeons (ACoS) have taken a leadership role in developing survivorship guidelines and quality metrics. Both ASCO and ACoS have focused their efforts on the treatment summary and care plan, a document that was proposed in the 2006 Institute of Medicine report on cancer survivorship. ASCO has proposed a care plan template for implementation and incorporation into the electronic health records (EHR), which will lend itself to structure, process, and outcome measurement. ACoS, conversely, has included the care plan in its cancer program standards with annual evaluation metrics. In addition, ASCO has developed a number of key survivorship-relevant metrics as part of its Quality Oncology Practice Initiative (QOPI), a tool developed to measure quality cancer care and assess adherence to guidelines across academic and community practices. Together, these efforts will direct us to more effective ways to disseminate guideline recommendations and to better methods of assessing quality survivorship care nationally.
authors.affiliation: From the School of Nursing, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Dubin Breast Center, Translational Breast Cancer Research, Tisch Cancer Institute, Mount Sinai Medical Center, Division of Hematology/Medical Oncology, Tisch Cancer Institute, New York, NY; Clinical Programs, Survivorship Center, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Deborah K
authors.initials: DK
authors.lastname: Mayer
authors.affiliation: From the School of Nursing, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Dubin Breast Center, Translational Breast Cancer Research, Tisch Cancer Institute, Mount Sinai Medical Center, Division of Hematology/Medical Oncology, Tisch Cancer Institute, New York, NY; Clinical Programs, Survivorship Center, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Shapiro
authors.affiliation: From the School of Nursing, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Dubin Breast Center, Translational Breast Cancer Research, Tisch Cancer Institute, Mount Sinai Medical Center, Division of Hematology/Medical Oncology, Tisch Cancer Institute, New York, NY; Clinical Programs, Survivorship Center, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Paul
authors.initials: P
authors.lastname: Jacobson
authors.affiliation: From the School of Nursing, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Dubin Breast Center, Translational Breast Cancer Research, Tisch Cancer Institute, Mount Sinai Medical Center, Division of Hematology/Medical Oncology, Tisch Cancer Institute, New York, NY; Clinical Programs, Survivorship Center, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Mary S
authors.initials: MS
authors.lastname: McCabe
mesh_terms: D003695:Delivery of Health Care; D057286:Electronic Health Records; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D011787:Quality of Health Care; D017741:Survivors; D014481:United States